international technology forum

International
Technology Forum
In vitro-Diagnostics and Bioanalysis 2014
June 12 – 13, 2014 | Berlin | Germany
Programme
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Organized by:
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Join our annual meeting and get insights in the latest trends
for the development of in vitro-Diagnostics!
Scientific Lectures
presenting the latest
trends in the development
of diagnostics
Industrial Exhibition
showcasing products,
services and technologies
In cooperation with:
Partnering
with pre-scheduled
one-to-one meetings for
companies and research
institutes
Supported by:
Accompanied by
Guided Science Tour to Labor Berlin
Guided City Tour “Berlin”
More Information: www.b2match.eu/techforum2014
International Technology Forum
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Perspectives and Challenges
of New Biomarker Development
Your partner for next
Generation in vitroDiagnostics
Welcome
The Science & Innovation Team at the British Embassy Berlin is pleased to support this year’s International Technology
Forum. We are honoured to have two excellent speakers
from the UK highlighting just some of the great work taking
place on stratified medicine across the UK.
Professor Pirmohamed is chair of the UK’s Pharmacogenetics and Stratified Medicine Network, a research network
whose main aim is to develop collaborations between academics, clinicians and industry partners, with the purpose
of catalysing research opportunities within the fast growing
field of stratified medicine. The Network works closely with
the UK’s innovation agency, the Technology Strategy Board,
to support expansion and drive forward the aim of making
the UK a world leader in stratified medicine.
Facing the economical and medical challenges,
new biomarkers and innovative diagnostics become more and more significant for the health
care systems of the future. As basis for individualized therapy decisions, predictive testing is one of
the key drivers for the next generation of in vitrodiagnostics.
Antonis Kousoulis is Academic Research Liaison at the Clinical Practice Research Datalink, which is the new English
NHS observational data and interventional research service,
jointly funded by the NHS National Institute for Health Research (NIHR) and the Medicines and Healthcare products
Regulatory Agency (MHRA). CPRD services are designed
to maximise the way anonymised NHS clinical data can be
linked to enable many types of observational research and
deliver research outputs that are beneficial to improving and
safeguarding public health.
Catapult Centre Network
The Technology Strategy Board (TSB) is supporting the setting up of a network of Catapult centres. A Catapult is a
technology and innovation centre where the very best of the
UK‘s businesses, scientists and engineers can work side by
side on research and development, transforming ideas into
new products and services to generate economic growth.
For many years now, the Berlin-Brandenburg Technology
Forum on “In vitro-Diagnostics and Bioanalysis” has been
an excellent platform for initiating a sustainable dialogue
between fundamental research, industrial development and
clinical application. But research and development do not
stop on regional borders. So it is with the Technology Forum. Bearing in mind the stronger national and international
development, not only the title has been changed – also renowned speakers from Germany and the European Union
have been invited to present their latest research. United
Kingdom – as this year’s partner country - supported the
organizers in the formation of the program.
Again, a specially designed partnering event for diagnostic
companies and research institutes will facilitate to meet
new co-operation partners from Europe for fostering and
encouraging possible growth opportunities. Companies will
present their latest developments and products during the
Industrial Exhibition. Participants will have the opportunity
to join a Guided Science Tour to Labor Berlin and a Guided
City Tour to Berlin.
This June, the International Technology Forum will be once
again the place to be for discussing new trends and topics in
the area of biomarker and in vitro-diagnostics for neuro-degenerative diseases, pandemia-relevant infection diseases
as well as cardiac- and nutritional- related diseases.
International Technology Forum
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Programme
Perspectives and Challenges
of New Biomarker Development
Programme
Thursday, June 12
Friday, June 13th
Guided Science Tour to Labor Berlin (15:00)
The laboratories of Charité and Vivantes have been merged
into one company: Labor Berlin. In order to go innovative
ways in laboratory diagnostics and to provide highest
quality services to patients, the competencies of both were
combined.
Welcome Address (9:00)
Rudolf Tauber, Charité – Universitätsmedizin Berlin, Berlin,
Germany | Simon Gallagher, British Embassy, Berlin, Germany
th
Welcome Reception (18:00)
Welcome Address
Roland Hetzer, Deutsches Herzzentrum Berlin, Berlin, Germany
Kai Bindseil, Clustermanager Gesundheitswirtschaft
Berlin-Brandenburg – HealthCapital, Germany
Welcome Lectures
Biomarker Strategy at Sanofi Aventis
Kathrin Heermeier, Sanofi Aventis Deutschland GmbH,
Frankfurt am Main, Germany
Diagnostics and Stratified Medicine in the UK: Changing
paradigms in clinics and patient treatment
Munir Pirmohamed, University of Liverpool, Liverpool, United
Kingdom
Opening Lectures
Chair: Rudolf Tauber - Universitätsmedizin Berlin
09:15Personalized healthcare 3.0: Vision & implications
for in vitro-diagnostics
Achim Plum, Siemens AG, Vienna, Austria
09:40Biomarker and personalized medicine – From
candidate to clinical application
The clinical point of view: Joachim Thiery,
Universi-tätsklinikum Leipzig, Leipzig, Germany
The industrial point of view: Guido Schütte, Roche
Diagnostics Deutschland GmbH, Mannheim,
Germany
10:30Coffee
Session I: Biomarker and Clinical Research
Chair: Joachim Thiery, Universitätsklinikum Leipzig
11:00Key Note: Current needs for the diagnosis of neurodegenerative disorders: Can in vitro tools solve the
problem?
Etienne Hirsch, Institut Thématique Multi-organismes
Neurosciences, Sciences cognitives, Neurologie,
Psychiatrie, Paris, France
11.25Towards personalized nutrition – What does it mean
for diagnostic demands in the future?
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Hannelore Daniel, Technische Universität München,
München, Germany
11.50Non-invasive analysis of cancer genome with
circulating tumour DNA
Florent Mouliere, University of Cambridge,
Cambridge, United Kingdom
12.15The route to diagnostics of relevance in developing
countries
Mark Perkins, Foundation for Innovative New
Diagnostics, Geneva, Switzerland
12.40Lunch
Session II: Technology Development
Chair: Achim Plum, Siemens AG
13.40Key Note: UK’s leadership position on Stratified
Medicine and data protection in the era of Big Data
Antonis A. Kousoulis, Clinical Practice Research
Datalink (CPRD), London, United Kingdom
14.05Circulating miRNAs and lncRNAs as diagnostic tools
in various diseases
Thomas Thum, Medizinische Hochschule Hannover,
Hannover, Germany
14.30Will glycane based assays become relevant for
tumor diagnostics?
Véronique Blanchard, Charité – Universitätsmedizin
Berlin, Berlin, Germany
14.50T(h)eraDiagnostics platform and perspectives for
future development of IVD
Frank F. Bier, Fraunhofer IBMT, Potsdam, Germany
15.10Microfluidic flow cytometers for blood cell
differentiation
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Jörg Neukammer, Physikalisch-Technische Bundesanstalt, Berlin, Germany
15.30Coffee
Session III: Industrial Development – Medical Application
Chair: Jens Fuhrmann, Thermo Scientific Biomarkers
16.00 Key Note: Metabolites in heart disease studies
Frank Beutner, Herzzentrum Leipzig, Leipzig,
Germany
16.20Early diagnosis of heart failure - from discovery to
a targeted assay
Tim Boelke, Metanomics Health GmbH, Berlin,
Germany
16.40Automatic analysis of DNA double strand breaks via
ɣH2AX-Foci – A potential marker for individual radioand chemosensitivity
Christina Fritz, Medipan GmbH, Dahlewitz, Germany
16.50The vibrant development of IVD industry in China and
how to benefit from it
Chao Xu, Osmunda Medical Device Service GmbH,
Berlin, Germany
17.00
Funding opportunities for Biomarker-research in
Horizon 2020
Wolfgang Korek, Berlin Partner für Wirtschaft und
Technologie GmbH, Berlin, Germany
17.30 Guided City Tour
Join us for a walk through the historical heart of Berlin
lead by professional guides just after the Technology
Forum. The tour will end in a relaxed dinner. Guided
tour is free of charge, dinner is to be paid individually.
International Technology Forum
Perspectives and Challenges
of New Biomarker Development
Your benefits from the
Partnering Event:
■Showcase your profile to other participants of the event
■Organize yourself: individual pre-scheduled one-to-one
meetings with the help of a web-based online tool
■Meet potential business, technological or research
partners for future co-operation
■Develop partnerships leading to technological and
commercial collaboration
■Establish cross-border contacts for long-term business
relationships
Biocat Katalonien Barcelona ES
BioWales Swansea GB
BioWin Wallonia Liège BE
Euromediag Languedoc-Roussillon Montpellier FR
Life Science Cluster Krakau PL
Lyonbiopôle Lyon FR
Nexxus East of Scotland Edinburgh GB
Oxfordshire Bioscience Network Oxford GB
UppsalaBio Uppsala SE
ZMDB/Berlin Partner Berlin-Brandenburg DE
EDCA unites the strengths of Europe’s
diagnostics clusters for scientific
excellence and economic growth!
Main Objectives
»» Facilitating the growth of European SMEs in medical diagnostics
»» Promoting cooperations between diagnostic clusters
»» Internationalizing of diagnostics development by European
collaborative projects
Whom you will meet:
■Developers and producers of in vitro-diagnostics
■Service providers
■Suppliers
■Distributors
■Research institutions
The earlier you submit your collaboration profile,
the more it will be noticed.
Participation in the Technology Forum (lectures, industrial
exhibition) is free of charge.The fee for the partnering
event amounts € 50 (VAT not included).Please note that
the Welcome Reception on June 12th, will take place at
the Deutsches Herzzentrum Berlin. Due to limited space,
participation is only possible on special invitation (interest
can be indicated upon registration).
More information and registration at:
www.b2match.eu/techforum2014
The European Diagnostic Clusters Alliance unites around 400 diagnostic companies in 7 EU countries and is fully supporting the event,
making it a real European quality brand for SME-directed diagnostic
partnering.
Contact
Berlin Partner für Wirtschaft und Technologie GmbH
Zentrum für Molekulare Diagnostik und Bioanalytik (ZMDB)
Dr. Günter Peine
[email protected] | www. zmdb.de
Venue
Charité – Universitätsmedizin Berlin
Campus Virchow-Klinikum
Forum 3, Lehrgebäude
Augustenburger Platz 1 | 13353 Berlin
The Center for Molecular Diagnostics and Bioanalysis (ZMDB) is a Flagship Project of
the Joint Innovation Strategy Berlin-Brandenburg at Berlin Partner for Business and
Technology GmbH. The ZMDB is funded by the states of Berlin and Brandenburg and
co-financed by the European Regional Development Fund (ERDF) of the European Union. An investment in your future!